Skip to content
EntityQ3706873· pop 11· linked from 112 articles

Dibekacin ('''3',4'-dideoxykanamycin B''') is an aminoglycoside antibiotic. It is a semisynthetic derivative of kanamycin developed by Hamao Umezawa and collaborators for Meiji Seika.

Research

643 papers

via PubMed

~1 min read

Encyclopedic overview

1 sections
Contents
  • References

Dibekacin ('''3',4'-dideoxykanamycin B''') is an aminoglycoside antibiotic. It is a semisynthetic derivative of kanamycin developed by Hamao Umezawa and collaborators for Meiji Seika.

It has been used in combination with sulbenicillin.

Excerpted from Wikipedia’s “dibekacin” article, available under the CC BY-SA 4.0 licence.